Carly Levine
InvestorSenior Associate at AMR Action Fund
United States
Writes $100K – $5M checks · typically $1.5M
About
Joined the fund as an analyst in 2021 with expertise in drug resistance biology and novel antibiotic development. Holds a PhD in microbiology from Rutgers University.
Experience
- AMR Action FundSenior Associatecurrent2025 — present
- AMR Action FundAssociate2023 — 2025
- AMR Action FundVenture Analyst2021 — 2023Boston, Massachusetts, United States
- Elion TherapeuticsBoard Observercurrent2024 — presentNew York, United States
- Pattern BioscienceBoard Directorcurrent2024 — present
- Pattern BioscienceBoard Observer2023 — 2024Austin, Texas, United States
- Venatorx Pharmaceuticals, Inc.Board Director2024 — 2025
- Venatorx Pharmaceuticals, Inc.Board Observer2022 — 2024Malvern, Pennsylvania, United States
- BioVersys AGBoard Director2023 — 2025Basel, Switzerland
- ANTABIOBoard Observer2023 — 2024Labège, Occitanie, France
- Adaptive Phage TherapeuticsBoard Observer2022 — 2024Gaithersburg, Maryland, United States
- Rutgers New Jersey Medical SchoolResearch Teaching Specialist2016Newark, New Jersey, United States
- Rutgers New Jersey Medical SchoolResearch Teaching Specialist2014 — 2016Newark, New Jersey, United States
Education
- Columbia Business SchoolCorporate Governance Program
- Weill Cornell Graduate School of Medical SciencesAcceleration BioVenture Innovation Training Program2021
- Rutgers University–New BrunswickTechnology Transfer Fellowship Program2021
- Rutgers University–NewarkDoctor of Philosophy - PhD, Biomedical Sciences2016 — 2021
- Rutgers University–NewarkMaster of Science - MS, Biomedical Sciences2013 — 2014
- University of TampaBachelor of Science - BS, Biology2010 — 2013
Skills & more
Research3Decontamination2Project Management2Laboratory SkillsMolecular BiologyScienceScientific WritingDrug DiscoveryData AnalysisMicrobiologyAnalytical SkillsLeadership1
+2 more
Microsoft PowerPointMicrosoft ExcelFrom Carly's professional profile.
Same school
Also attended Weill Cornell Graduate School of Medical Sciences8
Julie YangInvestor at Third Rock VenturesTracy WilliamsInvestor at Third Rock VenturesStella PaffenholzSenior Associate at Atlas VentureSahil ChopraPrincipal at Vertex Ventures HCXinghuo LiSenior Associate at Frazier Life SciencesCristina GhenoiuPartner at Mubadala Capital
+ 2 more
Also attended Rutgers University–New Brunswick6
Also attended Rutgers University–Newark9
Christian JaagBoard Member at CV VCAlejandro MartíVenture Partner at FaberKeith TitanPartner at BDMIChristopher de SouzaDirector at Broadview VenturesKhushboo PatelChief Operating Officer at Salesforce VenturesKen GustavsenMSD at i3 — Investing in Innovation Africa
+ 3 more
Also attended University of Tampa6
Shared employers
Also worked at Elion Therapeutics1
Also worked at Pattern Bioscience1
Also worked at ANTABIO1
Also worked at Rutgers New Jersey Medical School2
Colleagues at AMR Action Fund
Bill Burns
Board Chair at AMR Action Fund
Chris Sweeney
Executive Director, Communications and Media Relations at AMR Action Fund
Corinna Ruppli
Office Manager at AMR Action Fund
David Hellmuth
General Counsel and COO at AMR Action Fund
Deepali Patel
Director of International Policy at AMR Action Fund
Dorothy Maloney
Compliance Officer at AMR Action Fund
Henni-Karoliina Ropponen
Venture Analyst at AMR Action Fund
Henry Skinner
CEO at AMR Action Fund












.png)





















